temozolomide has been researched along with Porokeratosis in 1 studies
Porokeratosis: A heritable disorder of faulty keratinization characterized by the proliferation of abnormal clones of KERATINOCYTES and lesions showing varying atrophic patches surrounded by an elevated, keratotic border. These keratotic lesions can progress to overt cutaneous neoplasm. Several clinical variants are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis.
Excerpt | Relevance | Reference |
---|---|---|
"We report a case of temozolomide (TMZ)-induced inflammation of disseminated superficial actinic porokeratosis (DSAP), an uncommon and pre-malignant cutaneous disorder." | 7.88 | Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis. ( Gru, AA; Hamann, D; Kaffenberger, BH; Lee, DE, 2018) |
"We report a case of temozolomide (TMZ)-induced inflammation of disseminated superficial actinic porokeratosis (DSAP), an uncommon and pre-malignant cutaneous disorder." | 3.88 | Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis. ( Gru, AA; Hamann, D; Kaffenberger, BH; Lee, DE, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, DE | 1 |
Kaffenberger, BH | 1 |
Gru, AA | 1 |
Hamann, D | 1 |
1 other study available for temozolomide and Porokeratosis
Article | Year |
---|---|
Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis.
Topics: Antineoplastic Agents, Alkylating; Biopsy; Dacarbazine; Humans; Inflammation; Male; Middle Aged; Por | 2018 |